| For: | Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Kawamura Y, Yatsuji H, Sezaki H, Hosaka T, Hirakawa M, Saito S, Ikeda K, Kumada H. Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. World J Gastroenterol 2008; 14(38): 5880-5886 [PMID: 18855988 DOI: 10.3748/wjg.14.5880] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i38/5880.htm |
| Number | Citing Articles |
| 1 |
K. J. Williams. Gammaherpesviruses and Pulmonary Fibrosis. Veterinary Pathology 2014; 51(2) doi: 10.1177/0300985814521838
|
| 2 |
Doaa El Amrousy, Samir Hassan, Heba El Ashry. Chronic Hepatitis B Infection in Children and Its Relation to Pulmonary Function Tests: A Case-control Study. Pediatric Infectious Disease Journal 2020; 39(3) doi: 10.1097/INF.0000000000002543
|
| 3 |
|
| 4 |
Gaohong Sheng, Peng Chen, Yanqiu Wei, Huihui Yue, Jiaojiao Chu, Jianping Zhao, Yihua Wang, Wanguang Zhang, Hui-Lan Zhang. Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis. Chest 2020; 157(5) doi: 10.1016/j.chest.2019.10.032
|
| 5 |
Jun Yeun Cho, Mi Yeon Kim, Ji Hyoun Kim, Eung-Gook Kim, Sun-Hyung Kim, Bumhee Yang, Hyeran Kang, Ki Man Lee, Kang Hyeon Choe, Yoon Mi Shin. Characteristics and intrasubject variation in the respiratory microbiome in interstitial lung disease. Medicine 2023; 102(14) doi: 10.1097/MD.0000000000033402
|
| 6 |
Ameer Abutaleb, Shyam Kottilil, Elana Rosenthal. Viral Infections of Humans. 2022; doi: 10.1007/978-1-4939-9544-8_64-1
|
| 7 |
Hiroshi Kitazawa, Shigeo Kure. Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 2015; doi: 10.4137/CCRPM.S23282
|
| 8 |
Hamid Mattoo, Shiv Pillai. Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions. Cellular and Molecular Life Sciences 2021; 78(14) doi: 10.1007/s00018-021-03874-y
|
| 9 |
Sarocha Vivatvakin, Duangporn Werawatganon. Pulmonary Complications in Cirrhosis: Current Concepts and Clinical Perspectives. Biomedicines 2026; 14(7) doi: 10.3390/biomedicines14071499
|
| 10 |
Zeina Morcos, Chloe Lahoud, Waleed Azam, Mark Tawfik, Yisroel Grabie, Sudeep Acharya, Thomas Kilkenny. Unmasking Hepatitis C Infection: A Case Report of Interstitial Lung Disease as a Potential Extrahepatic Manifestation. Journal of Advanced Lung Health 2025; 5(3) doi: 10.4103/jalh.jalh_23_24
|
| 11 |
John W. Ward, Deborah Holtzman. Zakim and Boyer's Hepatology. 2018; doi: 10.1016/B978-0-323-37591-7.00029-X
|
| 12 |
Kevin Y. Huang, Enrico Petretto. Cross-species integration of single-cell RNA-seq resolved alveolar-epithelial transitional states in idiopathic pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 2021; 321(3) doi: 10.1152/ajplung.00594.2020
|
| 13 |
Elham A. Hassan, Mohamed O. Abdel Malek, Ali A. Hasan, Asmaa O. Ahmed. Does hepatitis C virus enhance prevalence of idiopathic pulmonary fibrosis and affect its severity? An Egyptian study. Egyptian Journal of Bronchology 2015; 9(1) doi: 10.4103/1687-8426.153655
|
| 14 |
Yufeng Zhang, Weilong Jiang, Qingqing Xia, Jia Qi, Mengshu Cao. Pharmacological mechanism of Astragalus and Angelica in the treatment of idiopathic pulmonary fibrosis based on network pharmacology. European Journal of Integrative Medicine 2019; 32 doi: 10.1016/j.eujim.2019.101003
|
| 15 |
Yukihiko Sugiyama. 5) Pulmonary Diseases and Abdominal Viscera.. Nihon Naika Gakkai Zasshi 2011; 100(9) doi: 10.2169/naika.100.2524
|
| 16 |
Kirat Gill, Hasmik Ghazinian, Richard Manch, Robert Gish. Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatology International 2016; 10(3) doi: 10.1007/s12072-015-9684-3
|
| 17 |
Robert Matthew KOTTMANN, Christopher M. HOGAN, Richard P. PHIPPS, Patricia J. SIME. Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology 2009; 14(7) doi: 10.1111/j.1440-1843.2009.01624.x
|
| 18 |
Francesco Negro, Daniel Forton, Antonio Craxì, Mark S. Sulkowski, Jordan J. Feld, Michael P. Manns. Extrahepatic Morbidity and Mortality of Chronic Hepatitis C. Gastroenterology 2015; 149(6) doi: 10.1053/j.gastro.2015.08.035
|
| 19 |
Barbara Deconinck, Johny Verschakelen, Johan Coolen, Eric Verbeken, Geert Verleden, Wim Wuyts. Diagnostic Workup for Diffuse Parenchymal Lung Disease: Schematic Flowchart, Literature Review, and Pitfalls. Lung 2013; 191(1) doi: 10.1007/s00408-012-9433-5
|
| 20 |
Daniel M. Provencher, Andrew R. Jauregui. Recommendations for evaluating and managing idiopathic pulmonary fibrosis. JAAPA 2018; 31(9) doi: 10.1097/01.JAA.0000544299.00459.a4
|
| 21 |
S. Pianko, S. Zeuzem, W.‐L. Chuang, G. R. Foster, S. K. Sarin, R. Flisiak, C.‐M. Lee, P. Andreone, T. Piratvisuth, S. Shah, A. Sood, J. George, M. Gould, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, Y. Li, M. Pang, Y. Yin, G. Feutren, I. M. Jacobson. Randomized trial of albinterferon alfa‐2b every 4 weeks for chronic hepatitis C virus genotype 2/3. Journal of Viral Hepatitis 2012; 19(9) doi: 10.1111/j.1365-2893.2012.01586.x
|
| 22 |
Simone Vasilij Benatti, Quinzan Giampaolo, Bigoni Sara, Rizzi Marco, Ripamonti Diego. Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients. AIDS 2014; 28(17) doi: 10.1097/QAD.0000000000000464
|
| 23 |
Tu H. Mai, Lyrialle W. Han, Joy C. Hsu, Nikhil Kamath, Lin Pan. Idiopathic pulmonary fibrosis therapy development: a clinical pharmacology perspective. Therapeutic Advances in Respiratory Disease 2023; 17 doi: 10.1177/17534666231181537
|
| 24 |
Andrea T. Borchers, Christopher Chang, Carl L. Keen, M. Eric Gershwin. Idiopathic Pulmonary Fibrosis—an Epidemiological and Pathological Review. Clinical Reviews in Allergy & Immunology 2011; 40(2) doi: 10.1007/s12016-010-8211-5
|
| 25 |
Fiorella Calabrese, Anja Kipar, Francesca Lunardi, Elisabetta Balestro, Egle Perissinotto, Emanuela Rossi, Nazarena Nannini, Giuseppe Marulli, James P. Stewart, Federico Rea, Martin RJ. Kolb. Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis. PLoS ONE 2013; 8(2) doi: 10.1371/journal.pone.0055715
|
| 26 |
Kazuyoshi Kuwano, Jun Araya, Hiromichi Hara. Idiopathic Pulmonary Fibrosis. 2016; doi: 10.1007/978-4-431-55582-7_2
|
| 27 |
Masami Minemura, Kazuto Tajiri, Yukihiro Shimizu. Systemic abnormalities in liver disease. World Journal of Gastroenterology 2009; 15(24): 2960-2974 doi: 10.3748/wjg.15.2960
|
| 28 |
Li Yen Goh, Tim Card, Andrew W. Fogarty, Tricia M. McKeever. The association of exposure to hepatitis B and C viruses with lung function and respiratory disease: A population based study from the NHANES III database. Respiratory Medicine 2014; 108(12) doi: 10.1016/j.rmed.2014.10.006
|
| 29 |
Qinyan Yin, Michael J. Strong, Yan Zhuang, Erik K. Flemington, Naftali Kaminski, Joao A. de Andrade, Joseph A. Lasky. Assessment of viral RNA in idiopathic pulmonary fibrosis using RNA-seq. BMC Pulmonary Medicine 2020; 20(1) doi: 10.1186/s12890-020-1114-1
|
| 30 |
Manzoor M. Khan. Is Immune Response Relevant in Interstitial Lung Disease?. Current Immunology Reviews 2020; 16(1) doi: 10.2174/1573395516999200914143054
|
| 31 |
Thị Hằng Giang Phan, Panagiotis Paliogiannis, Gheyath K. Nasrallah, Roberta Giordo, Ali Hussein Eid, Alessandro Giuseppe Fois, Angelo Zinellu, Arduino Aleksander Mangoni, Gianfranco Pintus. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis. Cellular and Molecular Life Sciences 2021; 78(5) doi: 10.1007/s00018-020-03693-7
|
| 32 |
Lucija Kuna, Jelena Jakab, Robert Smolic, George Y Wu, Martina Smolic. HCV Extrahepatic Manifestations. Journal of Clinical and Translational Hepatology 2019; 7(X) doi: 10.14218/JCTH.2018.00049
|
| 33 |
Daniel Kramer, Robert Hilton, Jesse Roman. Pulmonary fibrosis and COVID-19. The American Journal of the Medical Sciences 2023; 366(4) doi: 10.1016/j.amjms.2023.07.006
|
| 34 |
P. Spagnolo, S. Zeuzem, L. Richeldi, R. M. Du Bois. The complex interrelationships between chronic lung and liver disease: a review. Journal of Viral Hepatitis 2010; 17(6) doi: 10.1111/j.1365-2893.2010.01307.x
|
| 35 |
Paschalis Ntolios, Vassilios Tzilas, Evangelos Bouros, Eleni Avdoula, Ioannis Karakasiliotis, Demosthenes Bouros, Paschalis Steiropoulos. The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis. Biomedicines 2021; 9(4) doi: 10.3390/biomedicines9040442
|
| 36 |
Cosmin Dascalu, Karen Mrejen-Shakin, Sabiha Bandagi. Adalimumab-Induced Acute Pneumonitis in a Patient With Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology 2010; 16(4) doi: 10.1097/RHU.0b013e3181df8361
|
| 37 |
Won-Il Choi, Sonila Dauti, Hyun Jung Kim, Sun Hyo Park, Jae Seok Park, Choong Won Lee. Risk factors for interstitial lung disease: a 9-year Nationwide population-based study. BMC Pulmonary Medicine 2018; 18(1) doi: 10.1186/s12890-018-0660-2
|
| 38 |
Sevtap Doğan, Gözde Selvi Güldiken, Burcu Alpaslan, Serap Argun Barış, Nurettin Özgür Doğan. Impact of COVID-19 pneumonia on interstitial lung disease: semi-quantitative evaluation with computed tomography. European Radiology 2023; 33(7) doi: 10.1007/s00330-023-09441-2
|
| 39 |
Ciro Romano, Giovanna Cuomo, Roberta Ferrara, Andrea Del Mastro, Sergio Esposito, Ausilia Sellitto, Luigi Elio Adinolfi. Uncommon immune-mediated extrahepatic manifestations of HCV infection. Expert Review of Clinical Immunology 2018; 14(12) doi: 10.1080/1744666X.2018.1538790
|
| 40 |
Gisli Jenkins. Demystifying pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 2020; 319(3) doi: 10.1152/ajplung.00365.2020
|
| 41 |
Bethany B. Moore, Thomas A. Moore. Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation. Annals of the American Thoracic Society 2015; 12(Supplement_2) doi: 10.1513/AnnalsATS.201502-088AW
|
| 42 |
Rena Kaneko, Masazumi Ogawa, Tomoyuki Iwata, Yasuyoshi An, Motoki Nakagawa, Satoshi Kusayanagi, Satoshi Kamisago, Tomoyuki Umeda, Yuzuru Sato. Ursodeoxycholic acid exacerbates peginterferon-induced interstitial pneumonia in a patient with hepatitis C. Clinical Journal of Gastroenterology 2009; 2(4) doi: 10.1007/s12328-009-0075-y
|
| 43 |
Ningzi Zang, Yingxu Wu, Pin Li, Yongming Liu, Shiwen Wang, Jiapeng Leng, Libin Zhan, Xiaodong Lyu, Lijian Pang, Jiaran Wang. Viral Pathogens and Pulmonary Fibrosis: EMT‐Driven Mechanisms and Insights From Traditional Chinese Medicine. Reviews in Medical Virology 2026; 36(2) doi: 10.1002/rmv.70118
|
| 44 |
Mary Grace Jacob, Saji Sebastian, Geo Paul, Mukundan Chelakkat, Ajmal NM, Breezy Anna Joy, Mohammed Afsal. Echocardiographic abnormalities in patients with chronic liver disease. MGM Journal of Medical Sciences 2021; 8(4) doi: 10.4103/mgmj.mgmj_84_21
|
| 45 |
Isis E. Fernandez, Oliver Eickelberg. Precision in Pulmonary, Critical Care, and Sleep Medicine. Respiratory Medicine 2020; doi: 10.1007/978-3-030-31507-8_11
|
| 46 |
Payal K Naik, Bethany B Moore. Viral infection and aging as cofactors for the development of pulmonary fibrosis. Expert Review of Respiratory Medicine 2010; 4(6) doi: 10.1586/ers.10.73
|
| 47 |
Ameer Abutaleb, Shyam Kottilil, Elana Rosenthal. Viral Infections of Humans. 2026; doi: 10.1007/978-1-4939-9544-8_64-2
|
| 48 |
Natalya Azadeh, Andrew H. Limper, Eva M. Carmona, Jay H. Ryu. The Role of Infection in Interstitial Lung Diseases. Chest 2017; 152(4) doi: 10.1016/j.chest.2017.03.033
|
| 49 |
Suh-Young Lee, Sun-Sin Kim, So-Hee Lee, Heung-Woo Park. Chronic viral hepatitis accelerates lung function decline in smokers. Clinical and Experimental Medicine 2022; 23(6) doi: 10.1007/s10238-022-00963-5
|
| 50 |
Paolo Spagnolo, Philip L. Molyneaux, Nicol Bernardinello, Elisabetta Cocconcelli, Davide Biondini, Federico Fracasso, Mariaenrica Tiné, Marina Saetta, Toby M. Maher, Elisabetta Balestro. The Role of the Lung’s Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis. International Journal of Molecular Sciences 2019; 20(22) doi: 10.3390/ijms20225618
|
| 51 |
Anthony Shadid, Haydn E. Rich, Hunter DeVaughn, Aleksey Domozhirov, Marie- Françoise Doursout, Tingting Weng-Mills, Kristin L. Eckel-Mahan, Harry Karmouty-Quintana, Marcos I. Restrepo, Pooja Shivshankar. Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into non-typeable Haemophilus influenza pathogenesis. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1479801
|
| 52 |
|
| 53 |
Kurt Williams, Jesse Roman. Studying human respiratory disease in animals – role of induced and naturally occurring models. The Journal of Pathology 2016; 238(2) doi: 10.1002/path.4658
|
| 54 |
Wiwin Is Effendi, Tatsuya Nagano. The Crucial Role of NLRP3 Inflammasome in Viral Infection-Associated Fibrosing Interstitial Lung Diseases. International Journal of Molecular Sciences 2021; 22(19) doi: 10.3390/ijms221910447
|
| 55 |
Mohamed Kamal Shaker, Heba Mohamed Abdella, Osama Abdel-Hameed Hetta, Mohamed Nasser Abbas. Interstitial pulmonary changes in patients with hepatitis C-related chronic liver disease. Arab Journal of Gastroenterology 2010; 11(3) doi: 10.1016/j.ajg.2010.07.002
|
| 56 |
Alondra Esthefanía Llamas Domínguez, Julio Augusto Palma Zapata, Jose Luis Parra-Herrera, Juan Manuel Diaz, Silvia Denise Ponce-Campos. Autoimmune interstitial lung disease and hepatitis C, an interesting association: Two case reports. Medical Reports 2024; 5 doi: 10.1016/j.hmedic.2024.100066
|
| 57 |
G. R. Foster, S. Zeuzem, S. Pianko, S. K. Sarin, T. Piratvisuth, S. Shah, P. Andreone, A. Sood, W.‐L. Chuang, C.‐M. Lee, J. George, M. Gould, R. Flisiak, I. M. Jacobson, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, R. Sola, I. Messina, Y. Yin, S. Cammarata, G. Feutren, K. K. Brown. Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. Journal of Viral Hepatitis 2013; 20(4) doi: 10.1111/jvh.12020
|
| 58 |
Philip L. Molyneaux, Toby M. Maher. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis. European Respiratory Review 2013; 22(129) doi: 10.1183/09059180.00000713
|
| 59 |
K.V. Pandit, N. Kaminski. Translating MicroRNAs to the Clinic. 2017; doi: 10.1016/B978-0-12-800553-8.00007-X
|
| 60 |
Daniel Segna, Jean-François Dufour. Other Extrahepatic Manifestations of Hepatitis C Virus Infection (Pulmonary, Idiopathic Thrombocytopenic Purpura, Nondiabetes Endocrine Disorders). Clinics in Liver Disease 2017; 21(3) doi: 10.1016/j.cld.2017.03.014
|
| 61 |
Abd El Monaem Rabea, Mohamad Zidan, Rasha Daabis, Perihan El Sayed, Sally Samir. Prevalence of chronic hepatitis C virus (HCV) infection in patients with idiopathic pulmonary fibrosis. Egyptian Journal of Chest Diseases and Tuberculosis 2015; 64(4) doi: 10.1016/j.ejcdt.2015.07.003
|
| 62 |
|
| 63 |
Skender Topi, Elona Gaxhja, Ioannis Alexandros Charitos, Marica Colella, Luigi Santacroce. Hepatitis C Virus: History and Current Knowledge. Gastroenterology Insights 2024; 15(3) doi: 10.3390/gastroent15030049
|
| 64 |
Frequency of restrictive pulmonary function tests in patients with chronic Hepatitis C. Pakistan Journal of Surgery and Medicine 2024; 1(4) doi: 10.37978/pjsm.v1i4.223
|
| 65 |
Bernt van den Blink, Marlies S. Wijsenbeek, Henk C. Hoogsteden. Serum biomarkers in idiopathic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics 2010; 23(6) doi: 10.1016/j.pupt.2010.08.001
|